주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기
통합검색
로그인
고객센터
주요메뉴
질환포커스
세계의약뉴스
메디컬포커스
컨퍼런스
CME
근골격계
남성건강
내분비대사계
면역계
비뇨기계
심혈관계
여성건강
종양
호흡기계
감각기관계
중추신경계
소화기계
감염계
혈액 및 조혈계
최근 해외학술대회의 주요 발표내용을 제공합니다.
컨퍼런스 커버리지
Asian Pacific Digestive Week (APDW) 2021
19 August - 22 August. 2021, Malaysia
ACEIs/ARBs prevent hepatocellular carcinoma, cirrhotic complications in NAFLD
2022-01-14
Treatment with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) results in a reduced risk of hepatocellular carcinoma (HCC) and cirrhotic complications in patients with nonalcoholic fatty liver disease (NAFLD), particularly among those with chronic kidney disease (CKD), according to a study presented at the virtual Asian Pacific Digestive Disease Week (APDW) 2021.
Best practices for gastroesophageal reflux disease in Asia-Pacific
2022-01-14
The treatment of gastroesophageal reflux disease (GERD) continues to rely on proton pump inhibitors (PPIs), but advances in the field take account of new management options, such as antireflux surgery for reflux hypersensitivity and diaphragmatic breathing in refractory GERD or rumination, as pointed out during a lecture presented at this year’s virtual Asian Pacific Digestive Week (APDW 2021).
Circulating tumour cells signal more aggressive HCC
2022-01-14
Circulating tumour cells are more frequently detected in peripheral blood samples of patients with more advanced than early-stage hepatocellular carcinoma (HCC), according to a study presented at the recently concluded Asian Pacific Digestive Week 2021.
Does PPI use affect clinical outcomes in COVID-19 patients?
2022-01-14
According to a Hong Kong study presented at APDW 2021, the use of proton pump inhibitors (PPIs) is not associated with adverse clinical outcomes in individuals with COVID-19.
GI symptoms do not predict outcomes in adult COVID-19 patients
2022-01-14
The presence of gastrointestinal (GI) symptoms does not appear to significantly contribute to any clinical outcomes in adult patients admitted for COVID-19, reveals a retrospective study in the Philippines.
Oral n-acetyl cysteine may prevent post-ERCP acute pancreatitis
2022-01-14
Use of the oral antioxidant and anti-inflammatory n-acetyl cysteine (NAC) – be it alone or in combination with rectal indomethacin – may prevent the occurrence of post-ERCP* acute pancreatitis (PEAP), according to findings from a study presented at APDW 2021.
Southeast Asia’s gastroenterologists buckle under heavy burnout burden amid COVID-19
2022-01-14
During the coronavirus disease 2019 (COVID-19) pandemic, burnout has become prevalent among gastroenterologists in Southeast Asia, driven strongly by fears of getting infected and the stress of reduced income, according to a Singapore study presented at the recently concluded Asian Pacific Digestive Week 2021 (APDW 2021).
Vonoprazan bests PPIs in relieving GERD symptoms in latest meta-analysis
2022-01-14
The potassium-competitive acid blocker vonoprazan appears to be more effective than proton pump inhibitors (PPIs) in healing severe erosive esophagitis and relieving the symptoms of gastroesophageal reflux disease (GERD), according to a meta-analysis presented at APDW 2021.
Vonoprazan-based regimen shows treatment potential against H. pylori
2022-01-14
A 14-day quadruple therapeutic regimen containing vonoprazan – a first-in-class potassium-competitive acid blocker (P-CAB) with reportedly stronger acid inhibition than proton pump inhibitors – provided an excellent cure rate for
Helicobacter pylori
(
H. pylori
) infection in patients with high clarithromycin and quinolone resistance regardless of CYP3A4/5 genotypic polymorphism, according to the prospective VQ-HP trial presented at APDW 2021.
1
최근 본 콘텐츠
최근 본 콘텐츠가 없습니다
관심제품
관심콘텐츠
